Brazil to purchase single-shot CanSino Biologics COVID-19 vaccine
16 June 2021 -

Brazil plans to buy 60 million doses of the single-shot COVID-19 vaccine developed by China's CanSino Biologics for delivery in the third and fourth quarters of this year, Reuters news agency reported on Wednesday.

According to a negotiation document reviewed by Reuters, a ministry official signed a letter of intent on 4 June 2021 to purchase the vaccine doses with Belcher Farmaceutica do Brasil, a Brazilian pharmaceutical company that represents CanSino in Brazil.

This vaccine, trade-named Convidecia and developed by CanSino together with a research institute linked to the Chinese military, will cost USD17 per dose, the document said.